Insulet Corporation Price to Sales Ratio (PS) Ratios, (PODD) Valuation Ranking and Trends, Fundamental Ratios

PODD Price to Sales Ratio	(Sep 30 2025)	(Jun 30 2025)	(Mar 31 2025)	(Dec 31 2024)	(Sep 30 2024)
Sales Trailing 12 Months	III. Quarter	II. Quarter	I. Quarter	IV. Quarter	III. Quarter
Price to Sales (TTM) Ratio	current 9.32	9.02	8.91	9.29	8.12
Revenue TTM Y / Y Change	27.12 %	25.99 %	23.49 %	22.07 %	27.42 %
Revenue Y / Y Change	29.86 %	32.88 %	28.82 %	17.2 %	25.7 %
Stock performance	to date 16.77 %	15.24 %	-9.54 %	18.15 %	17.38 %

Price to sales ratio Comment

Insulet Corporation's current Price to sales ratio has increased due to shareprice growth of 16.77 %, from beginning of III. Quarter and despite Revenue increase of 29.86 %, to Price to Sales of 9.32, from average Price to sales ratio in II. Quarter of 9.02.

Within Healthcare sector 472 other companies have lower Price to sales ratio.

What is Price to Sales Ratio?
Sales growth by Insulet Corporation Segment

Price to sales ratio Company Ranking
Within:	No.
Industry	#165
Sector	#473
S&P 500	#3898

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.